QUIBIM HOSTING EUSOMII ANNUAL MEETING 2019
Next 18th and 19th October 2019, Valencia will host the Annual Meeting of the EUSOMII society (AMI2019). The society has planned a two days congress…
CURSO PROPIO: Introducción a la Inteligencia Artificial aplicada a la Imagen Médica
Tenemos el placer de anunciar la primera edición de nuestro curso: Introducción a la Inteligencia Artificial aplicada a la Imagen Médica. Se trata del primer curso teórico-práctico centrado en…
Imaging Biomarkers in Alzheimer
Alzheimer’s disease (AD) is a neurodegenerative disorder considered the most common cause of dementia worldwide. Dementia is a general term for the loss of cognitive…
QUIBIM made huge strides in
AI-powered diagnosis thanks to EU H2020
Taking part in the EU’s H2020 initiative translated into huge strides in disease detection and diagnosis by QUIBIM, by enabling the development of tools powered…
QUIBIM to develop platform in leading research project to fight pediatric cancer
QUIBIM is helping to advance knowledge of the most lethal pediatric tumors through EU-funded program PRIMAGE, which exploits precision information from medical imaging to establish…
IMAGING BIOMARKERS IN MULTIPLE SCLEROSIS
Pain, depression, slurred speech and feeling of numbness, tingling, or weakness. These are just some symptoms of Multiple Sclerosis (MS) disease, a long-term condition that…